1

Scientists: Slushy snowmelt isn’t just a nuisance

February 13, 2026

Slushy snowmelt isn’t just a nuisance, scientists say. It can send a toxic flood of road salt, sand and car exhaust, as well as dog poop, into rivers and streams, The University of Cincinnati College of Medicine's Yevgen Nazarenko, PhD, assistant professor of environmental and industrial hygiene in the Department of Environmental and Public Health Sciences, recently told The New York Times that research has shined a light on how pollution from all sorts of vehicles — planes, cars, trucks — can get trapped in the snow.

2

Can Cincinnati become a Blue Zone?

February 12, 2026

Under the Blue Zones Project umbrella, 75 U.S. cities currently are working on group diet and exercise programs while also changing the community’s culture, so that residents are encouraged to make healthy choices. Cincinnati is not an official Blue Zones Project city yet, but Florence Rothenberg, MD, adjunct professor of cardiology at the University of Cincinnati College of Medicine and clinical cardiologist at the Cincinnati VA Medical Center, is leading one public effort to encourage a Blue Zone lifestyle. Her work was recently featured in Cincinnati Magazine.

4

UC’s research surges with $346M in awards

February 12, 2026

The University of Cincinnati reached $346 million in sponsored research awards in fiscal year 2025, up 6.6% increase over the previous year. Additionally, funding for clinical trials at UC climbed, with $88 million in industry-sponsored awards and $33 million in federally sponsored awards.

5

UC Cancer Center taps new director

February 11, 2026

The Cincinnati Business Courier spoke with David Gius, MD, PhD, who was recently named the next director of the University of Cincinnati Cancer Center.

6

UC trial tests new nonpharmacological treatments for depression

February 11, 2026

The University of Cincinnati’s Fabiano Nery, MD, PhD, has received a five-year, approximately $3.5 million grant from the National Institutes of Health’s National Center for Complementary and Integrative Health to launch a clinical trial testing two new nonpharmacological treatments for teens and young adults with depression.

10

'Time is brain' again, now for control of intracerebral hemorrhage

February 5, 2026

MedPage Today highlighted research led by the University of Cincinnati's Joseph Broderick that found administering a synthetic protein can reduce bleeding and improve outcomes for certain patients at the highest risk of continued bleeding following a type of stroke called an intracerebral hemorrhage (ICH).

11

Children exposed to gambling mechanics before they understand money

February 4, 2026

Gambling-style mechanics are becoming a routine part of children’s digital lives, appearing in online games, mobile apps and even sports betting advertisements that surround popular media. University of Cincinnati experts warned in a recent WKRC-TV Local 12 report that long before children understand the value of money, they are learning the emotional highs and lows associated with risk. Online games, such as Roblox and Fortnite, offer fast-paced rewards that can keep children glued to screens.

12

Study: Synthetic protein potentially improves outcomes for certain subgroups following intracerebral hemorrhage

February 4, 2026

The University of Cincinnati’s Joseph Broderick, MD, presented results from the FASTEST trial at the International Stroke Conference, simultaneously published in The Lancet, that found administering a synthetic protein, recombinant Factor VIIa, can reduce bleeding and potentially improve outcomes for certain patients at the highest risk of continued bleeding following an intracerebral hemorrhage.

15

Cancer Center tests treatment using ‘glioblastoma-on-a-chip’ and wafer technology

February 3, 2026

A multidisciplinary team of University of Cincinnati Cancer Center researchers has received a $40,000 Ride Cincinnati grant to study the use of a delayed release preparation or wafer of an immunostimulatory molecule known as IL-15 to stimulate the central nervous system immune system after surgery to remove glioblastoma brain tumors.